Integrated healthcare solutions

Siemens Healthcare announced the signing of an agreement with Hospital Clinic in Barcelona, Spain, to integrate the use of laboratory diagnostics, imaging and information technology systems with the intent to improve management of patient care from early detection and diagnosis of diseases or conditions to patient treatment.

Under the agreement, Siemens and the Hospital Clinic will initially focus on three specific areas: liver fibrosis, fetal medicine and colon cancer.
By integrating patient information generated from the laboratory and imaging systems, physicians are able to receive integrated information about a patient more quickly, enabling them to make clinical decisions and possibly begin treatment sooner than before. In the long-term, this practice should allow for more patient-centric healthcare, improved clinical outcomes and cost savings to healthcare payers.
"Siemens Healthcare is the first company capable of offering integrated healthcare solutions, which we believe is the next generation of patient care,” said Donal Quinn, CEO, Siemens Healthcare Diagnostics. “By working together with Hospital Clinic, Barcelona, we will align technologies used to detect and treat several diseases or conditions so physicians can obtain more comprehensive patient information earlier, leading to improved quality of life for patients through earlier diagnosis and treatment."
The Hospital Clinic, Barcelona has a history of using new technology and concepts to advance healthcare research and patient care at their hospital. Siemens will work with the hospital’s experts in three specific areas—liver fibrosis, fetal medicine and colon cancer—to develop specific practices to increase early detection of diseases or abnormalities. These practices will be based on integrating patient data from the laboratory, imaging and information technology systems.
“This agreement allows us to build a platform for a new concept for patient care,” said Dr. Josep María Piqué, vice director, Hospital Clinic, Barcelona. “Integrated healthcare will benefit our patients in many ways including the possibility of replacing invasive testing methods, such as biopsy, with a combination of non-invasive testing methods. In the case of early detection of a prenatal condition, we hope to ensure the health of unborn babies.”
 

19.12.2008

Related articles

Photo

Sponsored • New Whitepaper

AI-Enabled Care Pathway: Shifting the Paradigm in Prostate Cancer Diagnosis

Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before biopsy, prostate MRI has become a critical decision point in the diagnostic…

Photo

Article • Equity, access, and the future of radiotherapy

Radiation oncology: the beam widens

Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the…

Photo

Sponsored • Earlier disease prediction and identification

The potential of AI in routine blood testing

It’s widely known that more than 70% of today’s medical decisions involve the results of laboratory tests, but the insights clinicians derive from these tests today may only be scratching the…

Subscribe to Newsletter